931
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Nucleoside diphosphate kinase B promotes osteosarcoma proliferation through c-Myc

, , , &
Pages 565-572 | Received 14 Jun 2017, Accepted 07 Dec 2017, Published online: 13 Apr 2018

References

  • Siegel R, Naishadham D, Jemal A. Cancer statistics 2013. CA Cancer J Clin. 2013;63:11–30. doi:10.3322/caac.21166. PMID:17562483.
  • Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008;112:416–32. doi:10.1002/cncr.23169. PMID:18074355.
  • Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RL Jr, Shows TB, Mathew S, Murty VV, Chaganti RS. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 1993;8:497–502. PMID:8381224.
  • Valentijn LJ, Koster J, Versteeg R. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Genomics 2006;87:483–9. doi:10.1016/j.ygeno.2005.11.004. PMID:16442775.
  • Postel EH, Berberich SJ, Flint SJ, Ferrone CA. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, candidate suppressor of tumor metastasis. Science 1993;261:478–80. doi:10.1126/science.8392752. PMID:8392752.
  • Schaertl S, Geeves MA, Konrad M. Human nucleoside diphosphate kinase B (Nm23-H2) from melanoma cells shows alteredphosphoryl transfer activity due to the S122P mutation. J Biol Chem 1999;274:20159–64. doi:10.1074/jbc.274.29.20159. PMID:10400630.
  • Lee MJ, Xu DY, Li H, Yu GR, Leem SH, Chu IS, Kim IH, Kim DG. Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma. Exp Mol Med 2012;44:214–24. doi:10.3858/emm.2012.44.3.016. PMID:22192927.
  • Tong Y, Yung LY, Wong YH. Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis. Cancer Lett 2015;361:207–17. doi:10.1016/j.canlet.2015.02.050. PMID:27987529.
  • Conacci-Sorrell M, McFerrin L, Eisenman RN. An overview of MYC and its interactome. Cold Spring Harb Perspect Med 2014;4:a014357. doi:10.1101/cshperspect.a014357. PMID:24384812.
  • Liu Z, Gan L, Luo D, Sun C. Melatonin promotes circadian rhythm-induced proliferation through Clock/histone deacetylase3/c-Myc interaction in mouse adipose tissue. J Pineal Res. 2017;62(4). doi:10.1111/jpi.12383. PMID:27987529
  • Gruppetta M, Formosa R, Falzon S, Ariff Scicluna S, Falzon E, Degeatano J, Vassallo J. Expression of cell cycle regulators and biomarkers of proliferation and regrowth in humanpituitary adenomas. Pituitary 2017;20:358–71. doi:10.1007/s11102-017-0803-0. PMID:28342098.
  • Dakic A, DiVito K, Fang S, Suprynowicz F, Gaur A, Li X, Palechor-Ceron N, Simic V, Choudhury S, Yu S, et al. ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of humankeratinocytes. Oncotarget 2016;7:66740–53. doi:10.18632/oncotarget.11458. PMID:27556514.
  • Schotanus BA, Kruitwagen HS, van den Ingh TS, van Wolferen ME, Rothuizen J, Penning LC, Spee B. Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cellniche. BMC Vet Res 2014;10:309. doi:10.1186/s12917-014-0309-1. PMID:25551829.
  • Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O'Neil J, Neuberg D, Weng AP. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 2006;103:18261–6. doi:10.1073/pnas.0606108103. PMID:17114293.
  • Romero OA, Verdura S, Torres-Diz M, Gomez A, Moran S, Condom E, Esteller M, Villanueva A, Sanchez-Cespedes M. Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming. Oncogene 2017;36:1287–96. doi:10.1038/onc.2016.296. PMID:27593925.
  • Zhang C, Xu B, Lu S, Zhao Y, Liu P. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Mol Cancer 2017;16:90. doi:10.1186/s12943-017-0656-1. PMID:28490334.
  • Zou K, Lu X, Ye K, Wang C, You T, Chen J. Krüppel-like factor 2 promotes cell proliferation in hepatocellular carcinoma through up-regulation of c-myc. Cancer Biol Ther 2016;17:20–6. doi:10.1080/15384047.2015.1108484. PMID:26853883.
  • Baker EK, Taylor S, Gupte A, Sharp PP, Walia M, Walsh NC, Zannettino AC, Chalk AM, Burns CJ, Walkley CR. BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. Sci Rep 2015;5:10120. doi:10.1038/srep10120. PMID:25944566.
  • Adamopoulos C, Gargalionis AN, Piperi C, Papavassiliou AG. Recent Advances in Mechanobiology of Osteosarcoma. J Cell Biochem 2017;118:232–6. doi:10.1002/jcb.25660. PMID:27463370.
  • Kopylov M, Bass HW, Stroupe ME. The maize (Zea mays L.) nucleoside diphosphate kinase1 (ZmNDPK1) gene encodes a humanNM23-H2 homologue that binds and stabilizes G-quadruplex DNA. Biochemistry 2015;54:1743–57. doi:10.1021/bi501284g. PMID:25679041.
  • Gilles AM, Presecan E, Vonica A, Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the twopolypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991;266:8784–9. PMID:1851158.
  • Wieland T, Hippe HJ, Ludwig K, Zhou XB, Korth M, Klumpp S. Reversible histidine phosphorylation in mammalian cells: a teeter-totter formed by nucleosidediphosphate kinase and protein histidine phosphatase 1. Methods Enzymol 2010;471:379–402. doi:10.1016/S0076-6879(10)71020-X. PMID:20946858.
  • Braun S, Mauch C, Boukamp P, Werner S. Novel roles of NM23 proteins in skin homeostasis, repair and disease. Oncogene 2007;26:532–42. doi:10.1038/sj.onc.1209822. PMID:16862176.
  • Bouvard C, Lim SM, Ludka J, Yazdani N, Woods AK, Chatterjee AK, Schultz PG, Zhu S. Small molecule selectively suppresses MYC transcription in cancer cells. Proc Natl Acad Sci U S A 2017;114:3497–502. doi:10.1073/pnas.1702663114. PMID:28292893.
  • Yao Y, Li C, Zhou X, Zhang Y, Lu Y, Chen J, Zheng X, Tao D, Liu Y, Ma Y. PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumorcell proliferation. Oncotarget 2014;5:8466–77. doi:10.18632/oncotarget.2327. PMID:25193865.
  • Tschiedel S, Bach E, Jilo A, Wang SY, Lange T, Al-Ali HK, Vucinic V, Niederwieser D, Cross M. Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and commonfeature of chronic myeloid leukemia. Leuk Lymphoma 2012;53:1569–76. doi:10.3109/10428194.2012.656631; PMID:22251158.
  • Wuelling M, Delling G, Kaiser E. Differential gene expression in stromal cells of human giant cell tumor of bone. Virchows Arch 2004;445:621–30. doi:10.1007/s00428-004-1113-2. PMID:15449052.
  • Böckelman C, Koskensalo S, Hagström J, Lundin M, Ristimäki A, Haglund C. CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol Ther 2012;13:289–95. doi:10.4161/cbt.18922. PMID:22310977.
  • Postel EH, Berberich SJ, Rooney JW, Kaetzel DM. Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr 2000;32:277–84. doi:10.1023/A:1005541114029. PMID:11768311.
  • Thakur RK, Kumar P, Halder K, Verma A, Kar A, Parent JL, Basundra R, Kumar A, Chowdhury S. Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoternuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res 2009;37:172–83. doi:10.1093/nar/gkn919. PMID:19033359.
  • Chang YW, Chiu CF, Lee KY, Hong CC, Wang YY, Cheng CC, Jan YH, Huang MS, Hsiao M, Ma JT, et al. CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis. Am J Respir Crit Care Med 2015;192:64–75. doi:10.1164/rccm.201411-1957OC. PMID:25906011.
  • Song JH, Park E, Kim MS, Cho KM, Park SH, Lee A, Song J, Kim HJ, Koh JT, Kim TS. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)2 D3 -induced myeloid differentiation in acute myeloid leukemia cells. Int J Cancer 2017;140:2364–74. doi:10.1002/ijc.30662; PMID:28224619.
  • Li X, Wu JB, Li Q, Shigemura K, Chung LW, Huang WC. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget 2016;7:12869–84. doi:10.18632/oncotarget.7331. PMID:26883200.
  • Galmozzi E, Casalini P, Iorio MV, Casati B, Olgiati C, Ménard S. HER2 signaling enhances 5′UTR-mediated translation of c-Myc mRNA. J Cell Physiol 2004;200:82–8. doi:10.1002/jcp.20012 doi:10.1002/jcp.20012. PMID:15137060.
  • Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, et al. Palbociclib and Letrozole in Advanced Breast Cancer. N Engl J Med. 2016;375:1925–36. doi:10.1056/NEJMoa1607303. PMID:27959613.
  • Borkowska A, Goryń T, Pieńkowski A, Wągrodzki M, Jagiełło-Wieczorek E, Rogala P, Szacht M, Rutkowski P. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone. Oncol Lett. 2016;12:4312–18. doi:10.3892/ol.2016.5246. PMID:28101196.
  • Claire Bouvard, Sang Min Lim, John Ludka, Nahid Yazdani, Ashley K. Woods, Arnab K. Chatterjee, eter G. Schultz, Shoutian Zhu. Small molecule selectively suppresses MYC transcription in cancer cells. Proc Natl Acad Sci U S A. 2017;114:3497–3502. doi:10.1073/pnas.1702663114. PMID:28292893

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.